Neurocrine Biosciences | NBIX - Résultat Par Action Eps


Fiscal Calendrier Actuel Consensus Précédent Date
FY2026Q3 Sep/2026 3.29 2.05 2.17 Nov/02
FY2026Q2 Jun/2026 2.85 1.58 1.65 Jul/30
FY2026Q1 Mar/2026 1.94 1.15 0.70 May/05
FY2025Q4 Dec/2025 1.88 1.86 1.69 Feb/11
FY2025Q3 Sep/2025 2.17 1.56 1.81 Oct/28




Eps Changement Date
AbbVie USD 3.82 0.17 2026-09
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
Agios Pharmaceuticals USD -1.09 0.6 2026-09
ALKERMES USD 0.09 0.09 2026-09
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
Amgen USD 6.45 0.16 2026-09
Biogen USD 2.62 0.98 2026-09
BioMarin Pharmaceutical USD 0.23 0.97 2026-09
Cytokinetics USD -1.37 0.13 2026-09
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Exelixis USD 0.94 0.03 2026-09
Gilead Sciences USD 2.55 9.3 2026-09
Halozyme Therapeutics USD 2.39 0.11 2026-09
Incyte USD -3.6 6.69 2026-09
Ionis Pharmaceuticals USD 0.66 1.35 2026-09
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 3.29 0.44 2026-09
Pfizer USD 0.87 0.1 2026-09
Prothena USD -0.36 0.96 2026-06
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Repligen USD 0.53 0.01 2026-09
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sarepta Therapeutics USD 0.13 0.51 2026-09
Teva Pharmaceutical Industries USD 0.79 0.73 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Vertex Pharmaceuticals USD 4.76 0.03 2026-09